Septic Arthritis Market Research Report - Forecast till 2027

Septic Arthritis Market Information: By Diagnosis (Joint Fluid Analysis, Blood Tests, Imaging), Treatment (Antibiotics, Surgery), Indication (Arthritis, Diabetes,), End User (Orthopedic Hospitals, Clinics, Diagnostic Centers) - Forecast till 2027

ID: MRFR/Pharma/3183-HCR | February 2021 | Region: Global | 110 pages

Market Synopsis of Septic Arthritis Market


Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include redness, heat, and pain in the joints reducing their movement. It is caused by bacteria, viruses, fungi, and parasites. Diabetes, osteoarthritis, gout, rheumatoid arthritis, joint trauma and poor immune function are major risk factors for septic arthritis.


The septic arthritis market is driven by an increasing prevalence of chronic diseases such as diabetes, rheumatoid arthritis, availability of cost effective treatment and extensive research and development activities in internal medicine. There is an increasing demand for the new drugs for the treatment of septic arthritis which further fuels the growth of the septic arthritis market.


Bacterial resistance to commonly used antibiotics such as vancomycin may restrain for the growth of the septic arthritis market. Fierce competition among key market players acts as a barrier for the new entrants in the septic arthritis market.


The septic arthritis market is expected to grow at a CAGR of 7.5% during the forecast period.


Segments                                                                                                                                            


The septic arthritis market is segmented on the basis of diagnosis, treatment, indication, and end user.


On the basis of diagnosis, septic arthritis market is segmented into joint fluid analysis, blood tests, imaging and others. Imaging is further segmented into X-ray, ultrasonography, MRI, and CT scan.


On the basis of treatment, the septic arthritis market is segmented into antibiotics, aspiration of the joint, surgery, and others. Surgery is further segmented into arthrotomy and arthroscopy.


On the basis of indication, the septic arthritis market is segmented into arthritis, hip or knee prosthesis, poor immune function, joint surgery, and others.


On the basis of end user, the septic arthritis market is segmented into orthopedic hospitals, clinics, pharmaceutical companies, and others.


FIGURE 1: Global Septic Arthritis Market by Region, 2016 (%) Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Research Methodology Global Septic Arthritis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation

Regional Analysis of theSeptic Arthritis Market                       


America is the largest market for septic arthritis owing to the rising prevalence of septic arthritis in the U.S., According to the Center for Disease Control and Prevention, an estimated 78 million (26%) U.S. adults aged 18 years or older are projected to have doctor-diagnosed arthritis by 2040. Furthermore, arthritis prevalence was the highest among people 65 years and older, women, and obese population.


Europe is the second largest septic arthritis market owing to the rising prevalence of rheumatoid arthritis in European countries and availability of funds for research and development activities.


The market in Asia Pacific is expected to grow at the fastest pace and is driven by the increasing geriatric population, rising prevalence of chronic disease such as diabetes, and obesity, and changing lifestyles of the people. Diabetes is one of the major problems further creating opportunities for the septic arthritis market growth.


The Middle East & Africa also show a steady rise in the market owing to increasing prevalence of diabetes and other chronic diseases.


Key Players in the Septic Arthritis Market        


Some of the key players in the septic arthritis market are Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.).


Intended Audience



  • Arthritis Drug Manufacturers

  • Arthritis Drug Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


 



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   7.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Diagnosis, Treatment, Indication, and End user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Lupin Pharmaceuticals, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Swtizerland), AbbVie Inc. (U.S.), Amgen Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Johnson & Johnson Inc. (U.S.), and Pfizer (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing prevalence of chronic diseases
  • Availability of cost effective treatment
  • Extensive research and development activities in internal medicine
  • Increasing demand for the new drugs for the treatment of septic arthritis


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The septic arthritis market CAGR would be 7.5% during the forecast period.

    The septic arthritis market report has joint fluid analysis, blood tests, imaging, and others as a part of diagnostic segmentation.

    The septic arthritis market report includes treatments like antibiotics, aspiration of the joint, surgery, and others.

    The Americas would lead the septic arthritis market.

    The APAC region would be the fastest-growing septic arthritis market.

    TABLE OF CONTENT

    Chapter 1. Report Prologue

    Chapter 2. Market Introduction

    2.1 Definition

    2.2 Scope of the Study

    2.2.1 Research Objective

    2.2.2 Assumptions

    2.2.3 Limitations

    Chapter 3. Research Methodology

    3.1 Introduction

    3.2 Primary Research

    3.3 Secondary research

    3.4 Market Size Estimation

    Chapter 4. Market Dynamics

    4.1 Drivers

    4.2 Restrains

    4.3 Opportunities

    4.4 Challenges

    4.5 Macroeconomic Indicators

    4.6 Technology Trends & Assessment

    Chapter 5. Market Factor Analysis

    5.1 Porters Five Forces Analysis

    5.1.1 Bargaining Power of Suppliers

    5.1.2 Bargaining Power of Buyers

    5.1.3 Threat of New Entrants

    5.1.4 Threat of Substitutes

    5.1.5 Intensity of Rivalry

    5.2 Value Chain Analysis

    5.3 Investment Feasibility Analysis

    5.4 Pricing Analysis

    Chapter 6. Global Septic Arthritis Market, by Diagnosis

    6.1 Introduction

    6.2 Joint Fluid Analysis

    6.2.1 Market Estimates & Forecast, 2020 – 2027

    6.3 Rotavirus

    6.3.1 Market Estimates & Forecast, 2020 – 2027

    6.4 Blood Tests

    6.4.1 Market Estimates & Forecast, 2020 – 2027

    6.5 Imaging

    6.5.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 7. Global Septic Arthritis Market, by Treatment

    7.1 Introduction

    7.2 Antibiotics

    7.2.1 Market Estimates & Forecast, 2020 – 2027

    7.3 Aspiration of the Joints

    7.3.1 Market Estimates & Forecast, 2020 – 2027

    7.4 Surgery

    7.4.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 8. Global Septic Arthritis Market, by Indication

    8.1 Introduction

    8.2 Arthritis

    8.2.1 Market Estimates & Forecast, 2020 – 2027

    8.3 Hip or Knee Prosthesis

    8.3.1 Market Estimates & Forecast, 2020 – 2027

    8.4 Poor Immune Function

    8.4.1 Market Estimates & Forecast, 2020 – 2027

    8.5 Joint Surgery

    8.5.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 9. Global Septic Arthritis Market, by End User

    9.1 Introduction

    9.2 Orthopedic Hospital

    9.2.1 Market Estimates & Forecast, 2020 – 2027

    9.3 Clinics

    9.3.1 Market Estimates & Forecast, 2020 – 2027

    9.4 Pharmaceutical Companies

    9.4.1 Market Estimates & Forecast, 2020 – 2027

    Chapter 10. Global Septic Arthritis Market, by Region

    10.1 Introduction

    10.2 America

    10.2.1 North America

    10.2.1.1 US

    10.2.1.1 Canada

    10.2.2 South America

    10.3 Europe

    10.3.1 Western Europe

    10.3.1.1 Germany

    10.3.1.2 France

    10.3.1.3 UK

    10.3.1.4 Italy

    10.3.1.5 Spain

    10.3.1.6 Rest of Western Europe

    10.3.2 Eastern Europe

    10.4 Asia Pacific

    10.4.1 Japan

    10.4.2 China

    10.4.3 India

    10.4.4 Australia

    10.4.5 Republic of Korea

    10.4.6 Rest of Asia Pacific

    10.5 The Middle East & Africa

    10.5.1 United Arab Emirates

    10.5.2 Saudi Arabia

    10.5.3 Oman

    10.5.4 Kuwait

    10.5.5 Qatar

    10.5.6 Rest of the Middle East & Africa

    Chapter 11 Company Landscape

    11.1 Introduction

    11.2 Market Share Analysis

    11.3 Key Development & Strategies

    11.3.1 Key Developments

    Chapter 12 Company Profiles

    12.1 Lupin Pharmaceuticals, Inc.

    12.1.1 Company Overview

    12.1.2 Product Overview

    12.1.3 Financials

    12.1.4 SWOT Analysis

    12.2 F. Hoffmann-La Roche Ltd

    12.2.1 Company Overview

    12.2.2 Product Overview

    12.2.3 Financial Overview

    11.2.4 Key Developments

    11.2.5 SWOT Analysis

    11.3 AbbVie Inc.

    11.3.1 Company Overview

    12.3.2 Product Overview

    12.3.3 Financial Overview

    12.3.4 Key Development

    12.3.5 SWOT Analysis

    12.4 Amgen Inc.

    12.4.1 Company Overview

    12.4.2 Product/Business Segment Overview

    12.4.3 Financial Overview

    12.4.4 Key Development

    12.4.5 SWOT Analysis

    12.5 Bristol-Myers Squibb Company

    12.5.1 Company Overview

    12.5.2 Product Overview

    12.5.3 Financial overview

    12.5.4 Key Developments

    12.6 Johnson & Johnson Inc.

    12.6.1 Company Overview

    12.6.2 Product Overview

    12.6.3 Financial Overview

    12.6.4 Key Developments

    12.7 Pfizer

    12.7.1 Overview

    12.7.2 Product Overview

    12.7.3 Financials

    12.7.4 Key Developments

    12.7.5 SWOT Analysis

    12.8 Others

    Chapter 13 MRFR Conclusion

    13.1 Key Findings

    13.1.1 From CEO’s View Point

    13.1.2 Unmet Needs of the Market

    13.2 Key Companies to Watch

    13.3 Prediction of Pharmaceutical Industry

    Chapter 14 Appendix

    LIST OF TABLES

    Table 1 Septic Arthritis Industry Synopsis, 2020 – 2027

    Table 2 Global Septic Arthritis Market Estimates and Forecast, 2020 – 2027, (USD Million)

    Table 3 Global Septic Arthritis Market by Region, 2020 – 2027, (USD Million)

    Table 4 Global Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 5 Global Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 6 Global Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 7 Global Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 8 North America Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 9 North America Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 10 North America Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 11 North America Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 12 South America Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 13 South America Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 14 South America Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 15 South America Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 16 Europe Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 17 Europe Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 18 Europe Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 19 Europe Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 20 Western Europe Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 21 Western Europe Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 22 Europe Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 23 Western Europe Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 24 Eastern Europe Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 25 Eastern Europe Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 26 Europe Septic Arthritis Market by Indication 2020 – 2027, (USD Million)

    Table 27 Eastern Europe Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 28 Asia Pacific Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 29 Asia Pacific Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 30 Asia Pacific Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)

    Table 31 Middle East & Africa Septic Arthritis Market by Diagnosis, 2020 – 2027, (USD Million)

    Table 32 Middle East & Africa Septic Arthritis Market by Treatment, 2020 – 2027, (USD Million)

    Table 33 Middle East & Africa Septic Arthritis Market by End Users, 2020 – 2027, (USD Million)


    LIST OF FIGURES

    Figure 1 Research Process

    Figure 2 Segmentation for Global Septic Arthritis Market

    Figure 3 Segmentation Market Dynamics for Septic Arthritis Market

    Figure 4 Global Septic Arthritis Market Share, by Diagnosis 2020

    Figure 5 Global Septic Arthritis Market Share, by Treatment 2020

    Figure 6 Global Septic Arthritis Market Share, by End Users, 2020

    Figure 7 Global Septic Arthritis Market Share, by Region, 2020

    Figure 8 North America Septic Arthritis Market Share, by Country, 2020

    Figure 9 Europe Septic Arthritis Market Share, by Country, 2020

    Figure 10 Asia Pacific Septic Arthritis Market Share, by Country, 2020

    Figure 11 Middle East & Africa Septic Arthritis Market Share, by Country, 2020

    Figure 12 Global Septic Arthritis Market: Company Share Analysis, 2020 (%)

    Figure 13 Lupin Pharmaceuticals, Inc.: Key Financials

    Figure 14 Lupin Pharmaceuticals, Inc.: Segmental Revenue

    Figure 16 Lupin Pharmaceuticals, Inc.: Geographical Revenue

    Figure 17 F. Hoffmann-La Roche Ltd: Key Financials

    Figure 18 F. Hoffmann-La Roche Ltd: Segmental Revenue

    Figure 19 F. Hoffmann-La Roche Ltd: Geographical Revenue

    Figure 20 AbbVie Inc.: Key Financials

    Figure 21 AbbVie Inc.: Segmental Revenue

    Figure 22 AbbVie Inc.: Geographical Revenue

    Figure 23 Amgen Inc.: Key Financials

    Figure 24 Amgen Inc.: Segmental Revenue

    Figure 25 Amgen Inc.: Geographical Revenue

    Figure 26 Bristol-Myers Squibb Company: Key Financials

    Figure 27 Bristol-Myers Squibb Company: Segmental Revenue

    Figure 28 Bristol-Myers Squibb Company: Geographical Revenue

    Figure 29 Johnson & Johnson Inc.: Key Financials

    Figure 30 Johnson & Johnson Inc.: Segmental Revenue

    Figure 31 Johnson & Johnson Inc.: Geographical Revenue

    Figure 32 Allergan: Key Financials

    Figure 33 Allergan: Segmental Revenue

    Figure 34 Allergan: Geographical Revenue